Edinburgh discovers accelerated aging syndrome
Analysis based on 7 articles · First reported Jun 30, 2026 · Last updated Jul 01, 2026
This discovery by the University of Edinburgh and its collaborators could significantly impact the biotechnology and pharmaceutical industries by opening new avenues for developing medicines to treat age-related diseases. Companies focused on anti-aging therapies and genetic research may see increased investment and interest.
Scientists, led by the University of Edinburgh, have discovered a rare genetic condition called Heyn-Sproul-Jackson syndrome (HESJAS) that causes accelerated aging. This breakthrough provides the first direct evidence that a 'biological clock' of DNA methylation actively contributes to age-related diseases, rather than merely measuring time. The study, funded by the Australia — Australian Research Council and the United Kingdom — Medical Research Council, found that individuals with HESJAS exhibit age-related health issues much earlier, including decreased blood cell production, osteoporosis, and hair loss. Mouse models also showed metabolic changes linked to diabetes and high cholesterol. This research, published in Nature Genetics, involved an international team including scientists from the University of Cambridge, the Institute of Cancer Research, the Spain — Spanish National Research Council, and hospitals across France, Norway, Mexico, New Zealand, and the United States. The findings are expected to support the design of future medicines to counter diseases linked to older age.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard